Epstein‐Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features
- 6 February 2008
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 99 (2) , 195-201
- https://doi.org/10.1111/j.1349-7006.2007.00674.x
Abstract
In this paper, the roles of Epstein-Barr virus (EBV) in gastric carcinogenesis are discussed, reviewing mainly epidemiological and clinicopathological studies. About 10% of gastric carcinomas harbor clonal EBV. LMP1, an important EBV oncoprotein, is only rarely expressed in EBV-associated gastric carcinoma (EBV-GC) while EBV-encoded small RNA is expressed in almost every EBV-GC cell, suggesting its importance for developing and maintaining this carcinoma. In addition, the hypermethylation-driven suppressor gene downregulation, frequently observed in EBV-GC, appears to give a selective advantage for carcinoma cells. EBV reactivation is suspected to precede EBV-GC development since antibodies against EBV-related antigens, including EBV capsid antigen (VCA), are elevated in prediagnostic sera. Interestingly, the average anti-VCA immunoglobulin G antibody titer in EBV-GC patients was significantly higher among men than among women, whereas EBV-negative GC cases did not show such a sex difference. A higher frequency of human leucocyte antigen-DR11 in EBV-GCs suggests that major histocompatibility complex-restricted EBV nuclear antigen 1 epitope recognition may enhance EBV reactivation. EBV infection of gastric cells by lymphocytes with reactivated EBV is suspected to be the first step of EBV-GC development. Male predominance of EBV-GC suggests the involvement of lifestyles and occupational factors common among men. The predominance of EBV with XhoI+ and BamHI type i polymorphisms in EBV-GC in Latin America suggests a possibility of some EBV oncogene expressions being affected by EBV polymorphism. The lack of such predominance in Asian countries, however, indicates an interaction between EBV polymorphism and the host response. In conclusion, further studies are necessary to examine the interaction between EBV infection, its polymorphisms, environmental factors, and genetic backgrounds.This publication has 38 references indexed in Scilit:
- Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decadesDiagnostic Pathology, 2007
- Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cellsProceedings of the National Academy of Sciences, 2006
- Association of a distinctive strain of Epstein‐Barr virus with gastric cancerInternational Journal of Cancer, 2005
- Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesisJournal of Clinical Pathology, 2004
- Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative CarcinomaClinical Cancer Research, 2004
- Epstein–Barr virus and microsatellite instability in gastric carcinogenesisThe Journal of Pathology, 2003
- Tumor Necrosis Factor–α and Interleukin‐10 Promoter Polymorphisms in Epstein‐Barr Virus–Associated Gastric CarcinomaThe Journal of Infectious Diseases, 2002
- Epstein‐Barr Virus‐associated Gastric Carcinoma in Japanese Brazilians and Non‐Japanese Brazilians in São PauloJapanese Journal of Cancer Research, 2001
- Epstein-Barr virus and gastric remnant cancerCancer, 1994
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985